Company intelligence / Profile preview

Strōma Medical

Irvine, California, United Statesstromamedical.com ↗

Ownership: Private
Employees: ~25
Development stage: Clinical

Overview

Strōma Medical has completed preliminary human safety and efficacy studies for its laser-based eye color change procedure. The company is currently conducting pilot clinical trials with about 20 patients and plans to expand to larger pivotal trials involving approximately 100 patients in multiple countries. Thus far, pre-clinical and early clinical data suggest the procedure does not cause pigmentary glaucoma or other major adverse events

Therapeutic areas: Ophthalmology
Modalities: DeviceLaser-based therapy (specifically, ophthalmic laser device)
Industry: Therapeutic Medical Devices

Partnerships

None publicly disclosed; intended partnerships with refractive surgeons/LASIK-certified ophthalmologists globally

Beyond the preview

Go deeper on Strōma Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Strōma Medical.

Explore the full profile